Biological
Granulocyte-colony stimulating factor
Granulocyte-colony stimulating factor is a biological therapy with 6 clinical trials. Historical success rate of 80.0%.
Total Trials
6
Max Phase
—
Type
BIOLOGICAL
Molecule
—
Success Metrics
Clinical Success Rate
80.0%
Based on 4 completed trials
Completion Rate
80%(4/5)
Active Trials
0(0%)
Results Posted
25%(1 trials)
Terminated
1(17%)
Phase Distribution
Ph phase_1
1
17%
Ph early_phase_1
1
17%
Ph phase_3
1
17%
Ph phase_2
3
50%
Phase Distribution
2
Early Stage
3
Mid Stage
1
Late Stage
Phase Distribution6 total trials
Early Phase 1First-in-human
1(16.7%)
Phase 1Safety & dosage
1(16.7%)
Phase 2Efficacy & side effects
3(50.0%)
Phase 3Large-scale testing
1(16.7%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
80.0%
4 of 5 finished
Non-Completion Rate
20.0%
1 ended early
Currently Active
0
trials recruiting
Total Trials
6
all time
Status Distribution
Active(1)
Completed(4)
Terminated(1)
Detailed Status
Completed4
Terminated1
Not yet recruiting1
Development Timeline
Analytics
Development Status
Total Trials
6
Active
0
Success Rate
80.0%
Most Advanced
Phase 3
Trials by Phase
Early Phase 11 (16.7%)
Phase 11 (16.7%)
Phase 23 (50.0%)
Phase 31 (16.7%)
Trials by Status
terminated117%
completed467%
not_yet_recruiting117%
Recent Activity
0 active trials
Showing 5 of 6
not_yet_recruitingphase_3
Decitabine and Umbilical Cord Blood for Poor Graft Function Post Allo-HSCT
NCT05669079
completedearly_phase_1
Survivin Vaccine : Multiple Myeloma Autologous Hematopoietic Cell Transplant (HCT)
NCT02851056
completedphase_2
Ofatumumab With IVAC Salvage Chemotherapy in Diffuse Large B Cell Lymphoma Patients
NCT01481272
completedphase_2
Autologous Transplant for Multiple Myeloma
NCT00177047
terminatedphase_1
Azacitidine in Haploidentical Donor Hematopoietic Cell Transplantation
NCT02750254
Clinical Trials (6)
Showing 6 of 6 trials
NCT05669079Phase 3
Decitabine and Umbilical Cord Blood for Poor Graft Function Post Allo-HSCT
NCT02851056Early Phase 1
Survivin Vaccine : Multiple Myeloma Autologous Hematopoietic Cell Transplant (HCT)
NCT01481272Phase 2
Ofatumumab With IVAC Salvage Chemotherapy in Diffuse Large B Cell Lymphoma Patients
NCT00177047Phase 2
Autologous Transplant for Multiple Myeloma
NCT02750254Phase 1
Azacitidine in Haploidentical Donor Hematopoietic Cell Transplantation
NCT00747708Phase 2
Bone Marrow Derived Adult Stem Cells for Chronic Heart Failure
All 6 trials loaded
Drug Details
- Intervention Type
- BIOLOGICAL
- Total Trials
- 6